HUE049813T2 - 3-((hetero-)aril)-alkil-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-dekán származékok - Google Patents
3-((hetero-)aril)-alkil-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-dekán származékokInfo
- Publication number
- HUE049813T2 HUE049813T2 HUE17701638A HUE17701638A HUE049813T2 HU E049813 T2 HUE049813 T2 HU E049813T2 HU E17701638 A HUE17701638 A HU E17701638A HU E17701638 A HUE17701638 A HU E17701638A HU E049813 T2 HUE049813 T2 HU E049813T2
- Authority
- HU
- Hungary
- Prior art keywords
- diaza
- spiro
- hetero
- oxo
- aryl
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16151013 | 2016-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE049813T2 true HUE049813T2 (hu) | 2020-10-28 |
Family
ID=55129634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17701638A HUE049813T2 (hu) | 2016-01-13 | 2017-01-13 | 3-((hetero-)aril)-alkil-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-dekán származékok |
Country Status (28)
| Country | Link |
|---|---|
| US (6) | US20170197947A1 (enExample) |
| EP (1) | EP3402784B1 (enExample) |
| JP (1) | JP6893517B2 (enExample) |
| KR (1) | KR20180098369A (enExample) |
| CN (1) | CN108602777B (enExample) |
| AR (1) | AR107360A1 (enExample) |
| AU (1) | AU2017206909B2 (enExample) |
| BR (1) | BR112018014303B1 (enExample) |
| CA (1) | CA3011177A1 (enExample) |
| CL (1) | CL2018001912A1 (enExample) |
| CO (1) | CO2018008444A2 (enExample) |
| CY (1) | CY1122818T1 (enExample) |
| DK (1) | DK3402784T3 (enExample) |
| EA (1) | EA037481B1 (enExample) |
| EC (1) | ECSP18060848A (enExample) |
| ES (1) | ES2797904T3 (enExample) |
| HR (1) | HRP20200837T1 (enExample) |
| HU (1) | HUE049813T2 (enExample) |
| IL (1) | IL260491B (enExample) |
| LT (1) | LT3402784T (enExample) |
| MX (1) | MX378994B (enExample) |
| PE (1) | PE20181375A1 (enExample) |
| PL (1) | PL3402784T3 (enExample) |
| PT (1) | PT3402784T (enExample) |
| RS (1) | RS60315B1 (enExample) |
| SI (1) | SI3402784T1 (enExample) |
| TW (1) | TWI636048B (enExample) |
| WO (1) | WO2017121648A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6893517B2 (ja) | 2016-01-13 | 2021-06-23 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ３−（（ヘテロ−）アリール）−アルキル−８−アミノ−２−オキソ−１，３−ジアザ−スピロ−［４．５］−デカン誘導体 |
| TWI635082B (zh) | 2016-01-13 | 2018-09-11 | 歌林達有限公司 | ３－（（雜－）芳基）－８－胺基－２－側氧－１,３－二氮雜－螺－［４.５］－癸烷衍生物 |
| DK3402783T3 (da) | 2016-01-13 | 2020-05-04 | Gruenenthal Gmbh | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater |
| MX378995B (es) | 2016-01-13 | 2025-03-11 | Gruenenthal Gmbh | Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. |
| RS60855B1 (sr) | 2016-01-13 | 2020-10-30 | Gruenenthal Gmbh | Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana |
| MX2020010999A (es) | 2018-04-18 | 2021-01-20 | Constellation Pharmaceuticals Inc | Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos. |
| EP3797108B1 (en) | 2018-05-21 | 2022-07-20 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| WO2020144375A1 (en) | 2019-01-11 | 2020-07-16 | Grünenthal GmbH | Substituted pyrrolidine amides iii |
| GB201905721D0 (en) | 2019-04-24 | 2019-06-05 | Univ Dundee | Compounds |
| PE20220562A1 (es) | 2019-07-24 | 2022-04-13 | Constellation Pharmaceuticals Inc | Formas cristalinas de 7-cloro-2-(4-(3-metoxiazetidin-1-il)ciclohexil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-oxo-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioxol-5-carboxamida |
| IL321707A (en) * | 2022-12-28 | 2025-08-01 | Gilgamesh Pharmaceuticals Inc | Synthesis of 2-phenyl-2-amino-cyclohexan-1-one history |
| US20240400537A1 (en) | 2023-04-25 | 2024-12-05 | Gruenenthal Gmbh | Cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2734265B1 (fr) | 1995-05-17 | 1997-06-13 | Adir | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant |
| RU2268883C2 (ru) | 2001-04-18 | 2006-01-27 | Эро-Селтик, С.А. | Аналоги ноницептина и фармацевтическая композиция на их основе |
| DE10130020A1 (de) | 2001-06-25 | 2003-12-04 | Gruenenthal Gmbh | Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate |
| DE10210195B4 (de) | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
| PT1519939E (pt) | 2002-07-05 | 2010-02-10 | Targacept Inc | Compostos n-arildiazaspirocíclicos e métodos para a sua preparação e utilização |
| DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| ZA200510329B (en) | 2003-05-23 | 2007-04-25 | Zealand Pharma As | Triaza-spiro compounds as nociceptin analogues and uses thereof |
| JO2676B1 (en) | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
| AU2007312391B2 (en) | 2006-10-19 | 2012-06-21 | F. Hoffmann-La Roche Ag | Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes |
| EP2150552B1 (en) | 2007-04-09 | 2013-01-02 | Janssen Pharmaceutica NV | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
| KR20120075500A (ko) * | 2008-03-27 | 2012-07-06 | 그뤼넨탈 게엠베하 | 치환된 4-아미노사이클로헥산 유도체 |
| US8268853B2 (en) | 2009-06-25 | 2012-09-18 | Abbott Laboratories | 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof |
| TWI582092B (zh) | 2010-07-28 | 2017-05-11 | 歌林達股份有限公司 | 順式－四氫－螺旋（環己烷－１,１’－吡啶［３,４－b］吲哚）－４－胺－衍生物 |
| WO2014106238A1 (en) * | 2012-12-31 | 2014-07-03 | Fang, Qun, Kevin | Heterocyclic compounds and methods of use thereof |
| EP3154971A4 (en) | 2014-06-13 | 2017-11-01 | Purdue Pharma L.P. | Heterocyclic morphinan derivatives and use thereof |
| MX378995B (es) | 2016-01-13 | 2025-03-11 | Gruenenthal Gmbh | Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. |
| JP6893517B2 (ja) | 2016-01-13 | 2021-06-23 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ３−（（ヘテロ−）アリール）−アルキル−８−アミノ−２−オキソ−１，３−ジアザ−スピロ−［４．５］−デカン誘導体 |
| DK3402783T3 (da) | 2016-01-13 | 2020-05-04 | Gruenenthal Gmbh | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater |
| TWI730032B (zh) | 2016-01-13 | 2021-06-11 | 美商必治妥美雅史谷比公司 | 作為ｒｏｃｋ抑制劑之螺庚烷水楊酸醯胺及相關化合物 |
| TWI635082B (zh) | 2016-01-13 | 2018-09-11 | 歌林達有限公司 | ３－（（雜－）芳基）－８－胺基－２－側氧－１,３－二氮雜－螺－［４.５］－癸烷衍生物 |
| RS60855B1 (sr) | 2016-01-13 | 2020-10-30 | Gruenenthal Gmbh | Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana |
| RU2747877C2 (ru) | 2016-01-13 | 2021-05-17 | Ново Нордиск А/С | Аналоги эфр(а) с заместителями - жирными кислотами |
-
2017
- 2017-01-13 JP JP2018536484A patent/JP6893517B2/ja not_active Expired - Fee Related
- 2017-01-13 PE PE2018001302A patent/PE20181375A1/es unknown
- 2017-01-13 CN CN201780006494.6A patent/CN108602777B/zh not_active Expired - Fee Related
- 2017-01-13 DK DK17701638.3T patent/DK3402784T3/da active
- 2017-01-13 BR BR112018014303-0A patent/BR112018014303B1/pt not_active IP Right Cessation
- 2017-01-13 MX MX2018008644A patent/MX378994B/es unknown
- 2017-01-13 HU HUE17701638A patent/HUE049813T2/hu unknown
- 2017-01-13 TW TW106101125A patent/TWI636048B/zh not_active IP Right Cessation
- 2017-01-13 EA EA201891609A patent/EA037481B1/ru unknown
- 2017-01-13 PT PT177016383T patent/PT3402784T/pt unknown
- 2017-01-13 KR KR1020187021562A patent/KR20180098369A/ko active Pending
- 2017-01-13 HR HRP20200837TT patent/HRP20200837T1/hr unknown
- 2017-01-13 PL PL17701638T patent/PL3402784T3/pl unknown
- 2017-01-13 LT LTEP17701638.3T patent/LT3402784T/lt unknown
- 2017-01-13 ES ES17701638T patent/ES2797904T3/es active Active
- 2017-01-13 US US15/405,896 patent/US20170197947A1/en not_active Abandoned
- 2017-01-13 SI SI201730268T patent/SI3402784T1/sl unknown
- 2017-01-13 EP EP17701638.3A patent/EP3402784B1/en active Active
- 2017-01-13 AU AU2017206909A patent/AU2017206909B2/en not_active Ceased
- 2017-01-13 CA CA3011177A patent/CA3011177A1/en active Pending
- 2017-01-13 AR ARP170100095A patent/AR107360A1/es unknown
- 2017-01-13 RS RS20200585A patent/RS60315B1/sr unknown
- 2017-01-13 WO PCT/EP2017/025006 patent/WO2017121648A1/en not_active Ceased
-
2018
- 2018-05-21 US US15/984,919 patent/US20180327392A1/en not_active Abandoned
- 2018-07-09 IL IL260491A patent/IL260491B/en unknown
- 2018-07-13 CL CL2018001912A patent/CL2018001912A1/es unknown
- 2018-08-13 CO CONC2018/0008444A patent/CO2018008444A2/es unknown
- 2018-08-13 EC ECSENADI201860848A patent/ECSP18060848A/es unknown
-
2019
- 2019-02-01 US US16/265,080 patent/US10829480B2/en active Active
-
2020
- 2020-05-04 CY CY20201100402T patent/CY1122818T1/el unknown
- 2020-08-31 US US17/007,258 patent/US20200399252A1/en not_active Abandoned
-
2021
- 2021-03-01 US US17/188,743 patent/US20210179592A1/en not_active Abandoned
-
2023
- 2023-01-30 US US18/103,180 patent/US20230174520A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL260491B (en) | History of 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
| IL264092A (en) | 1, 3-dihydroxy-phenyl derivatives are useful as immunomodulators | |
| IL285355A (en) | History of 3-((hetero-)aryl)-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
| IL260488B (en) | History of 8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
| IL260495B (en) | History of 3-(carboxyethyl)-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
| IL260497B (en) | History of 3-(Carboxymethyl)-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
| SG11201803584RA (en) | 1,4-dicarbonyl-piperidyl derivatives | |
| HRP20180585T1 (hr) | Spojevi 2,7-diazaspiro[3.5]nonana | |
| SI3796975T1 (sl) | Derivati sulfonilaminobenzamida | |
| IL260303B (en) | Process for preparing 3,1,1-trioxo-2,1-benzothiazole-6-carboxamide | |
| HUE040133T2 (hu) | Szubsztituált azaspiro(4.5)dekán származékok | |
| IL258217A (en) | 2,3,4,5 tetrahydropyridin-6-amine derivatives | |
| IL260306B (en) | Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide | |
| SI3484892T1 (sl) | Derivati 1,2,4-triazolo-(3,4-B)-1,3,4-tiadiazola | |
| GB201618461D0 (en) | Mrbr.3 | |
| HK1253837A1 (en) | Substituted 1,2-dihydro-3h |